429 related articles for article (PubMed ID: 12730604)
21. Loss of the astrocyte glutamate transporter GLT1 modifies disease in SOD1(G93A) mice.
Pardo AC; Wong V; Benson LM; Dykes M; Tanaka K; Rothstein JD; Maragakis NJ
Exp Neurol; 2006 Sep; 201(1):120-30. PubMed ID: 16753145
[TBL] [Abstract][Full Text] [Related]
22. No association with common Caucasian genotypes in exons 8, 13 and 14 of the human cytoplasmic dynein heavy chain gene (DNCHC1) and familial motor neuron disorders.
Ahmad-Annuar A; Shah P; Hafezparast M; Hummerich H; Witherden AS; Morrison KE; Shaw PJ; Kirby J; Warner TT; Crosby A; Proukakis C; Wilkinson P; Orrell RW; Bradley L; Martin JE; Fisher EM
Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):150-7. PubMed ID: 13129801
[TBL] [Abstract][Full Text] [Related]
23. Forme fruste or incipient form of widespread-type amyotrophic lateral sclerosis, or motor neuron disease with pallido-nigro-luysian atrophy? An autopsy case report.
Hashimoto T; Matsubara S; Mochizuki Y; Tsuji S; Mizutani T; Oyanagi K
Neuropathology; 2008 Jun; 28(3):309-16. PubMed ID: 18179405
[TBL] [Abstract][Full Text] [Related]
24. Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration.
LaMonte BH; Wallace KE; Holloway BA; Shelly SS; Ascaño J; Tokito M; Van Winkle T; Howland DS; Holzbaur EL
Neuron; 2002 May; 34(5):715-27. PubMed ID: 12062019
[TBL] [Abstract][Full Text] [Related]
25. Aberrant deltaPKC activation in the spinal cord of Wobbler mouse: a model of motor neuron disease.
Dave KR; Raval AP; Purroy J; Kirkinezos IG; Moraes CT; Bradley WG; Pérez-Pinzón MA
Neurobiol Dis; 2005 Feb; 18(1):126-33. PubMed ID: 15649703
[TBL] [Abstract][Full Text] [Related]
26. mnd2: a new mouse model of inherited motor neuron disease.
Jones JM; Albin RL; Feldman EL; Simin K; Schuster TG; Dunnick WA; Collins JT; Chrisp CE; Taylor BA; Meisler MH
Genomics; 1993 Jun; 16(3):669-77. PubMed ID: 8325640
[TBL] [Abstract][Full Text] [Related]
27. Intermediate chain subunit as a probe for cytoplasmic dynein function: biochemical analyses and live cell imaging in PC12 cells.
Myers KR; Lo KW; Lye RJ; Kogoy JM; Soura V; Hafezparast M; Pfister KK
J Neurosci Res; 2007 Sep; 85(12):2640-7. PubMed ID: 17279546
[TBL] [Abstract][Full Text] [Related]
28. CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA.
Suzuki K; Katsuno M; Banno H; Takeuchi Y; Atsuta N; Ito M; Watanabe H; Yamashita F; Hori N; Nakamura T; Hirayama M; Tanaka F; Sobue G
Brain; 2008 Jan; 131(Pt 1):229-39. PubMed ID: 18056738
[TBL] [Abstract][Full Text] [Related]
29. Androgen receptor function in motor neuron survival and degeneration.
Cary GA; La Spada AR
Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):479-94, viii. PubMed ID: 18625411
[TBL] [Abstract][Full Text] [Related]
30. Motor neuron degeneration in a horse.
Step DL; Cummings JF; de Lahunta A; Valentine BA; Summers BA; Rowland PH; Mohammed HO; Eckerlin RH; Rebhun WC
J Am Vet Med Assoc; 1993 Jan; 202(1):86-8. PubMed ID: 8420912
[TBL] [Abstract][Full Text] [Related]
31. A novel mutation (K317M) in the MAPT gene causes FTDP and motor neuron disease.
Zarranz JJ; Ferrer I; Lezcano E; Forcadas MI; Eizaguirre B; Atarés B; Puig B; Gómez-Esteban JC; Fernández-Maiztegui C; Rouco I; Pérez-Concha T; Fernández M; Rodríguez O; Rodríguez-Martínez AB; de Pancorbo MM; Pastor P; Pérez-Tur J
Neurology; 2005 May; 64(9):1578-85. PubMed ID: 15883319
[TBL] [Abstract][Full Text] [Related]
32. Neuroprotective effect of adult hematopoietic stem cells in a mouse model of motoneuron degeneration.
Cabanes C; Bonilla S; Tabares L; Martínez S
Neurobiol Dis; 2007 May; 26(2):408-18. PubMed ID: 17337196
[TBL] [Abstract][Full Text] [Related]
33. Widespread loss of neuronal populations in the spinal ventral horn in sporadic motor neuron disease. A morphometric study.
Stephens B; Guiloff RJ; Navarrete R; Newman P; Nikhar N; Lewis P
J Neurol Sci; 2006 May; 244(1-2):41-58. PubMed ID: 16487542
[TBL] [Abstract][Full Text] [Related]
34. [Role of caspases in neural degeneration in amyotrophic lateral sclerosis].
Sela B
Harefuah; 2001 Nov; 140(11):1100-4, 1115. PubMed ID: 11759391
[TBL] [Abstract][Full Text] [Related]
35. Mutant glycyl-tRNA synthetase (Gars) ameliorates SOD1(G93A) motor neuron degeneration phenotype but has little affect on Loa dynein heavy chain mutant mice.
Banks GT; Bros-Facer V; Williams HP; Chia R; Achilli F; Bryson JB; Greensmith L; Fisher EM
PLoS One; 2009 Jul; 4(7):e6218. PubMed ID: 19593442
[TBL] [Abstract][Full Text] [Related]
36. Disruption of axonal transport in motor neuron diseases.
Ikenaka K; Katsuno M; Kawai K; Ishigaki S; Tanaka F; Sobue G
Int J Mol Sci; 2012; 13(1):1225-1238. PubMed ID: 22312314
[TBL] [Abstract][Full Text] [Related]
37. A missense mutation in Tbce causes progressive motor neuronopathy in mice.
Martin N; Jaubert J; Gounon P; Salido E; Haase G; Szatanik M; Guénet JL
Nat Genet; 2002 Nov; 32(3):443-7. PubMed ID: 12389029
[TBL] [Abstract][Full Text] [Related]
38. Zebrafish models of human motor neuron diseases: advantages and limitations.
Babin PJ; Goizet C; Raldúa D
Prog Neurobiol; 2014 Jul; 118():36-58. PubMed ID: 24705136
[TBL] [Abstract][Full Text] [Related]
39. Spinal inhibitory circuits and their role in motor neuron degeneration.
Ramírez-Jarquín UN; Lazo-Gómez R; Tovar-Y-Romo LB; Tapia R
Neuropharmacology; 2014 Jul; 82():101-7. PubMed ID: 24157492
[TBL] [Abstract][Full Text] [Related]
40. Motor neuron diversity in development and disease.
Kanning KC; Kaplan A; Henderson CE
Annu Rev Neurosci; 2010; 33():409-40. PubMed ID: 20367447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
